OmniAb, Inc. Common Stock (OABI)

Price$2.61

Value ScoreD

Growth ScoreC

Momentum ScoreA

Favorite Metrics

Price vs S&P 500 (26W)45.75%

Price vs S&P 500 (4W)87.89%

VGM Score58.01

Market Capitalization$391.43M

All Metrics

Book Value / Share (Quarterly)$1.81

P/TBV (Annual)1.88x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-31.89%

Cash Flow / Share (Quarterly)$-0.18

Price vs S&P 500 (YTD)35.01%

Gross Margin (TTM)98.91%

Net Profit Margin (TTM)-187.59%

EPS (TTM)$-0.46

10-Day Avg Trading Volume0.87M

EPS Excl Extra (TTM)$-0.46

Revenue Growth (5Y)-4.31%

EPS (Annual)$-0.57

ROI (Annual)-24.26%

Gross Margin (Annual)98.38%

Net Profit Margin (5Y Avg)-169.17%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)247.30%

ROA (Last FY)-21.53%

Revenue Growth TTM (YoY)8.21%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)-16.00%

Operating Margin (TTM)-200.26%

Cash Flow / Share (Annual)$-0.26

P/B Ratio1.49x

P/B Ratio (Quarterly)0.87x

Net Income / Employee (Annual)$-727,900

EV / Revenue (TTM)12.52x

Net Interest Coverage (TTM)-3434.00x

ROA (TTM)-18.10%

EPS Incl Extra (Annual)$-0.57

Current Ratio (Annual)4.02x

Quick Ratio (Quarterly)4.58x

3-Month Avg Trading Volume0.55M

52-Week Price Return116.00%

Revenue / Employee (TTM)$325,200

Tangible BV / Share (Quarterly)$0.99

P/S Ratio (Annual)20.97x

Asset Turnover (Annual)0.06x

52-Week High$2.75

Operating Margin (5Y Avg)-200.51%

EPS Excl Extra (Annual)$-0.57

CapEx CAGR (5Y)-20.24%

26-Week Price Return61.68%

Quick Ratio (Annual)3.85x

13-Week Price Return50.00%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.80x

Enterprise Value$362.38M

Revenue / Share Growth (5Y)-4.06%

Asset Turnover (TTM)0.10x

Revenue / Employee (Annual)$209,700

Pretax Margin (Annual)-355.16%

Cash / Share (Annual)$0.37

3-Month Return Std Dev67.18%

Net Income / Employee (TTM)$-610,000

ROE (Last FY)-24.26%

EPS Basic Excl Extra (Annual)$-0.57

Receivables Turnover (TTM)3.03x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.46

Receivables Turnover (Annual)2.95x

ROI (TTM)-20.31%

P/S Ratio (TTM)13.53x

Pretax Margin (5Y Avg)-191.42%

Revenue / Share (Annual)$0.16

Tangible BV / Share (Annual)$0.98

Price vs S&P 500 (52W)87.79%

Year-to-Date Return45.95%

5-Day Price Return1.89%

EPS Normalized (Annual)$-0.57

ROA (5Y Avg)-13.65%

Net Profit Margin (Annual)-347.04%

Month-to-Date Return94.24%

Cash Flow / Share (TTM)$-0.10

EBITD / Share (Annual)$-0.49

Operating Margin (Annual)-369.49%

ROI (5Y Avg)-16.00%

EPS Basic Excl Extra (TTM)$-0.46

P/TBV (Quarterly)1.58x

P/B Ratio (Annual)1.00x

Pretax Margin (TTM)-190.93%

Book Value / Share (Annual)$1.85

Price vs S&P 500 (13W)40.25%

Beta0.42x

P/FCF (Annual)556.79x

Revenue / Share (TTM)$0.23

ROE (TTM)-20.31%

52-Week Low$1.22

vGradeD

gGradeC

mGradeA

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.06est. -0.10

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.23

Industry Peers — R&D — Physical Sciences(15)

Symbol	Value Score	Growth Score	Momentum Score	Price
OABIOmniAb, Inc. Common Stock	D	C	A	$2.61
IQVIQVIA Holdings Inc.	C	B	B	$186.82
INCYIncyte Genomics Inc	C	A	B	$95.59
MEDPMedpace Holdings, Inc. Common Stock	D	A	B	$451.47
ICLRIcon Plc	C	C	B	$138.03
CRLCharles River Laboratories International, Inc.	D	D	B	$182.07
ABSIAbsci Corporation Common Stock	F	F	A	$6.52
NRCNRC Health Common Stock	D	D	B	$20.25
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.22
ONMDOneMedNet Corp Class A Common Stock	D	C	C	$0.78
NOTVInotiv, Inc. Common Stock	B	B	D	$0.31

About

OmniAb licenses antibody discovery technology to pharmaceutical and biotech companies and academic institutions. The platform uses engineered transgenic animals powered by proprietary Biological Intelligence to rapidly identify optimized antibody candidates for drug development. The company generates revenue through licensing agreements that accelerate its partners' therapeutic discovery efforts.